StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical cash

Cash and short-term investments held at the end of each period.

Rockwell Medical's cash was $24.80M at Jun 30, 2026. For fiscal 2025 it was $25.00M, up 15.7% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $65.80M in fiscal 2014.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.00M+15.7%
FY2024Dec 31, 2024$21.60M+98.2%
FY2023Dec 31, 2023$10.90M-49.3%
FY2022Dec 31, 2022$21.50M-4.0%
FY2021Dec 31, 2021$22.40M-61.8%
FY2020Dec 31, 2020$58.70M+125.4%
FY2019Dec 31, 2019$26.05M-22.3%
FY2018Dec 31, 2018$33.53M+298.9%
FY2017Dec 31, 2017$8.41M-51.1%
FY2016Dec 31, 2016$17.18M-44.9%
FY2015Dec 31, 2015$31.20M-52.6%
FY2014Dec 31, 2014$65.80M+453.8%
FY2013Dec 31, 2013$11.88M+152.2%
FY2012Dec 31, 2012$4.71M-17.6%
FY2011Dec 31, 2011$5.72M-53.4%
FY2010Dec 31, 2010$12.26M-46.8%
FY2009Dec 31, 2009$23.04M+311.6%
FY2008Dec 31, 2008$5.60M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$24.80M+34.8%
Q1 FY2026Mar 31, 2026$23.90M+38.2%
Q4 FY2025Dec 31, 2025$25.00M+15.7%
Q3 FY2025Sep 30, 2025$23.70M+29.5%
Q2 FY2025Jun 30, 2025$18.40M+54.6%
Q1 FY2025Mar 31, 2025$17.30M+101.2%
Q4 FY2024Dec 31, 2024$21.60M+98.2%
Q3 FY2024Sep 30, 2024$18.30M+56.4%
Q2 FY2024Jun 30, 2024$11.90M-20.1%
Q1 FY2024Mar 31, 2024$8.60M-48.8%
Q4 FY2023Dec 31, 2023$10.90M-49.3%
Q3 FY2023Sep 30, 2023$11.70M-57.6%
Q2 FY2023Jun 30, 2023$14.90M-51.6%
Q1 FY2023Mar 31, 2023$16.80M+69.5%
Q4 FY2022Dec 31, 2022$21.50M-4.0%
Q3 FY2022Sep 30, 2022$27.60M-16.9%
Q2 FY2022Jun 30, 2022$30.78M-24.9%
Q1 FY2022Mar 31, 2022$9.91M-78.5%
Q4 FY2021Dec 31, 2021$22.40M-61.8%
Q3 FY2021Sep 30, 2021$33.20M-50.7%
Q2 FY2021Jun 30, 2021$41.00M+2.6%
Q1 FY2021Mar 31, 2021$46.10M-5.6%
Q4 FY2020Dec 31, 2020$58.70M+125.4%
Q3 FY2020Sep 30, 2020$67.32M+366.8%
Q2 FY2020Jun 30, 2020$39.96M+86.6%
Q1 FY2020Mar 31, 2020$48.86M+133.5%
Q4 FY2019Dec 31, 2019$26.05M-22.3%
Q3 FY2019Sep 30, 2019$14.42M+236.0%
Q2 FY2019Jun 30, 2019$21.42M+1125.1%
Q1 FY2019Mar 31, 2019$20.92M+538.2%
Q4 FY2018Dec 31, 2018$33.53M+298.9%
Q3 FY2018Sep 30, 2018$4.29M+10.4%
Q2 FY2018Jun 30, 2018$1.75M-79.3%
Q1 FY2018Mar 31, 2018$3.28M-72.6%
Q4 FY2017Dec 31, 2017$8.41M-51.1%
Q3 FY2017Sep 30, 2017$3.89M-79.8%
Q2 FY2017Jun 30, 2017$8.46M–
Q1 FY2017Mar 31, 2017$11.97M–
Q4 FY2016Dec 31, 2016$17.18M–
Q3 FY2016Sep 30, 2016$19.29M–

More Rockwell Medical figures

See a number that looks wrong?